Crohn's Disease-Associated Bacteria Tolerate Antibiotics
|
By LabMedica International staff writers Posted on 26 Nov 2019 |

Image: Axio Vert.A1 inverted microscope (Photo courtesy of Carl Zeiss)
Crohn's disease is a chronic disease that causes inflammation and irritation in the digestive tract. The disease is characterized by an imbalance in the intestinal microbiome. In particular, adherent-invasive Escherichia coli (AIEC) strains have been implicated in the disease.
The diversity of virulence factors displayed by multiple AIEC strains suggests that members of this pathovar have evolved different strategies to colonize their hosts. AIEC ability to persist, and in some cases replicate within macrophages is particularly intriguing. A reference strain for this pathovar, AIEC LF82, forms micro-colonies within phagolysosomes, an environment that prevents commensal E. coli multiplication.
Microbiologists at the Université Paris Sciences et Lettres (Paris, France) and their associates used single-cell analysis, genetic dissection and mathematical models to monitor the growth status and cell cycle regulation of intracellular AIEC LF82. The investigators infected cells resulting in the observation of three LF82 bacteria per macrophage on average at 1 hour. Imaging was performed on an inverted Zeiss Axio Imager (Jena, Germany) with a spinning disk CSU W1 (Yokogawa, Tokyo, Japan).
The team also performed antibiotic challenge and viable bacterial count using the gentamycin protection assay, fluorescence quantification, live and dead assays using the Live and Dead BacLight Viability kit (Thermo Fisher Scientific, Waltham, MA, USA), measurement of gene expression by RT-qPCR using a MyiQ real-time qPCR machine (Bio-Rad, Hercules, CA, USA).
The scientists reported that they found that within macrophages, bacteria may replicate or undergo non-growing phenotypic switches. This switch results from stringent response firing immediately after uptake by macrophages or at later stages, following genotoxic damage and SOS induction during intracellular replication. Importantly, non-growers resist treatment with various antibiotics. Thus, intracellular challenges induce AIEC LF82 phenotypic heterogeneity and non-growing bacteria that could provide a reservoir for antibiotic-tolerant bacteria responsible for relapsing infections. Importantly, non-growers resist treatment with various antibiotics.
The authors concluded that intracellular challenges induce AIEC LF82 phenotypic heterogeneity and non-growing bacteria that could provide a reservoir for antibiotic-tolerant bacteria responsible for relapsing infections. The study was published on November 14, 2019 in the journal PLOS Pathogens.
Related Links:
Université Paris Sciences et Lettres
Carl Zeiss
Yokogawa
Thermo Fisher Scientific
Bio-Rad
The diversity of virulence factors displayed by multiple AIEC strains suggests that members of this pathovar have evolved different strategies to colonize their hosts. AIEC ability to persist, and in some cases replicate within macrophages is particularly intriguing. A reference strain for this pathovar, AIEC LF82, forms micro-colonies within phagolysosomes, an environment that prevents commensal E. coli multiplication.
Microbiologists at the Université Paris Sciences et Lettres (Paris, France) and their associates used single-cell analysis, genetic dissection and mathematical models to monitor the growth status and cell cycle regulation of intracellular AIEC LF82. The investigators infected cells resulting in the observation of three LF82 bacteria per macrophage on average at 1 hour. Imaging was performed on an inverted Zeiss Axio Imager (Jena, Germany) with a spinning disk CSU W1 (Yokogawa, Tokyo, Japan).
The team also performed antibiotic challenge and viable bacterial count using the gentamycin protection assay, fluorescence quantification, live and dead assays using the Live and Dead BacLight Viability kit (Thermo Fisher Scientific, Waltham, MA, USA), measurement of gene expression by RT-qPCR using a MyiQ real-time qPCR machine (Bio-Rad, Hercules, CA, USA).
The scientists reported that they found that within macrophages, bacteria may replicate or undergo non-growing phenotypic switches. This switch results from stringent response firing immediately after uptake by macrophages or at later stages, following genotoxic damage and SOS induction during intracellular replication. Importantly, non-growers resist treatment with various antibiotics. Thus, intracellular challenges induce AIEC LF82 phenotypic heterogeneity and non-growing bacteria that could provide a reservoir for antibiotic-tolerant bacteria responsible for relapsing infections. Importantly, non-growers resist treatment with various antibiotics.
The authors concluded that intracellular challenges induce AIEC LF82 phenotypic heterogeneity and non-growing bacteria that could provide a reservoir for antibiotic-tolerant bacteria responsible for relapsing infections. The study was published on November 14, 2019 in the journal PLOS Pathogens.
Related Links:
Université Paris Sciences et Lettres
Carl Zeiss
Yokogawa
Thermo Fisher Scientific
Bio-Rad
Latest Microbiology News
- High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
- Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
- Rapid Sepsis Diagnostic Device to Enable Personalized Critical Care for ICU Patients
- Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
- New Diagnostic Method Confirms Sepsis Infections Earlier
- New Markers Could Predict Risk of Severe Chlamydia Infection
- Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
- CRISPR-Based Saliva Test Detects Tuberculosis Directly from Sputum
- Urine-Based Assay Diagnoses Common Lung Infection in Immunocompromised People
- Saliva Test Detects Implant-Related Microbial Risks
- New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance
- Early Detection of Gut Microbiota Metabolite Linked to Atherosclerosis Could Revolutionize Diagnosis
- Viral Load Tests Can Help Predict Mpox Severity
- Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
- Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
- Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
Channels
Clinical Chemistry
view channel
VOCs Show Promise for Early Multi-Cancer Detection
Early cancer detection is critical to improving survival rates, but most current screening methods focus on individual cancer types and often involve invasive procedures. This makes it difficult to identify... Read more
Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
Kidney disease is typically diagnosed through blood or urine tests, often when patients present with symptoms such as blood in urine, shortness of breath, or weight loss. While these tests are common,... Read moreMolecular Diagnostics
view channel
New Diagnostic Method Detects Pneumonia at POC in Low-Resource Settings
Pneumonia continues to be one of the leading causes of death in low- and middle-income countries, where limited access to advanced laboratory infrastructure hampers early and accurate diagnosis.... Read more
Blood Immune Cell Analysis Detects Parkinson’s Before Symptoms Appear
Early diagnosis of Parkinson’s disease remains one of the greatest challenges in neurology. The condition, which affects nearly 12 million people globally, is typically identified only after significant... Read moreHematology
view channel
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage
Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read moreImmunology
view channel
Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
Immunotherapy has revolutionized cancer care by harnessing the immune system to fight tumors, yet predicting who will benefit remains a major challenge. Many patients undergo costly and taxing treatment... Read more
Signature Genes Predict T-Cell Expansion in Cancer Immunotherapy
Modern cancer immunotherapies rely on the ability of CD8⁺ T cells to rapidly multiply within tumors, generating the immune force needed to eliminate cancer cells. However, the biological triggers behind... Read morePathology
view channel
New Molecular Analysis Tool to Improve Disease Diagnosis
Accurately distinguishing between similar biomolecules such as proteins is vital for biomedical research and diagnostics, yet existing analytical tools often fail to detect subtle structural or compositional... Read more
Tears Offer Noninvasive Alternative for Diagnosing Neurodegenerative Diseases
Diagnosing and monitoring eye and neurodegenerative diseases often requires invasive procedures to access ocular fluids. Ocular fluids like aqueous humor and vitreous humor contain valuable molecular information... Read moreTechnology
view channel
Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement
Sorting different cell types—such as cancerous versus healthy or live versus dead cells—is a critical task in biology and medicine. However, conventional methods often require labeling, chemical exposure,... Read more
Embedded GPU Platform Enables Rapid Blood Profiling for POC Diagnostics
Blood tests remain a cornerstone of medical diagnostics, but traditional imaging and analysis methods can be slow, costly, and reliant on dyes or contrast agents. Now, scientists have developed a real-time,... Read moreIndustry
view channel
Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
QIAGEN (Venlo, Netherlands) has entered into a definitive agreement to fully acquire Parse Biosciences (Seattle, WA, USA), a provider of scalable, instrument-free solutions for single-cell research.... Read more
Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
Puritan Medical Products (Guilford, ME, USA), the world’s most trusted manufacturer of swabs and specimen collection devices, is set to exhibit at AMP2025 in Boston, Massachusetts, from November 11–15.... Read more
Advanced Instruments Merged Under Nova Biomedical Name
Advanced Instruments (Norwood, MA, USA) and Nova Biomedical (Waltham, MA, USA) are now officially doing business under a single, unified brand. This transformation is expected to deliver greater value... Read more








